Presentation is loading. Please wait.

Presentation is loading. Please wait.

Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib  C. Leitner, R. von Moos,

Similar presentations


Presentation on theme: "Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib  C. Leitner, R. von Moos,"— Presentation transcript:

1 Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib  C. Leitner, R. von Moos, M. Mark, M. Früh, R. Cathomas  Cancer Treatment and Research Communications  Volume 2, Issue 1, Pages 4-7 (January 2014) DOI: /j.ctrc Copyright © 2014 The Authors Terms and Conditions

2 Figure 1 Magnetic resonance imaging (MRI) and computed tomography (CT) scans showing the process of brain metastases: at initial diagnosis (A), after first line therapy with whole brain radiation therapy (WBRT) and erlotinib (B), at first relapse (C), after repeated WBRT and continued erlotinib (D), at second relapse (E), after therapy with gefitinib (F). Cancer Treatment and Research Communications 2014 2, 4-7DOI: ( /j.ctrc ) Copyright © 2014 The Authors Terms and Conditions


Download ppt "Progressive brain metastases in an EGFR mutated adenocarcinoma of the lung: Response to gefitinib after progression on erlotinib  C. Leitner, R. von Moos,"

Similar presentations


Ads by Google